Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis

Epidemiological studies indicate that the consumption of caffeine, the most commonly ingested psychoactive substance found in coffee, tea or soft drinks, reduces the risk of developing Alzheimer’s disease (AD). Previous treatment studies with transgenic AD mouse models reported a reduced amyloid pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Stazi, Martina, Lehmann, Sandra, Sakib, M. Sadman, Pena-Centeno, Tonatiuh, Büschgens, Luca, Fischer, Andre, Weggen, Sascha, Wirths, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738505/
https://www.ncbi.nlm.nih.gov/pubmed/34913091
http://dx.doi.org/10.1007/s00018-021-04062-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738505/
https://www.ncbi.nlm.nih.gov/pubmed/34913091
http://dx.doi.org/10.1007/s00018-021-04062-8

Ejemplares similares